CymaBay Therapeutics, Inc.
Treatment of intrahepatic cholestatic diseases
Last updated:
Abstract:
Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.
Status:
Grant
Type:
Utility
Filling date:
18 Sep 2020
Issue date:
11 May 2021